Your browser doesn't support javascript.
loading
Robotic versus laparoscopic liver resections for hepatolithiasis: an international multicenter propensity score matched analysis.
Kwak, Bong Jun; Lee, Jae Hoon; Chin, Ken Min; Syn, Nicholas L; Choi, Sung Hoon; Cheung, Tan To; Chiow, Adrian K H; Sucandy, Iswanto; Marino, Marco V; Prieto, Mikel; Chong, Charing C; Choi, Gi Hong; Efanov, Mikhail; Kingham, T Peter; Sutcliffe, Robert P; Troisi, Roberto I; Pratschke, Johann; Wang, Xiaoying; D'Hondt, Mathieu; Tang, Chung Ngai; Mishima, Kohei; Wakabayashi, Go; Cherqui, Daniel; Aghayan, Davit L; Edwin, Bjorn; Scatton, Olivier; Sugioka, Atsushi; Long, Tran Cong Duy; Fondevila, Constantino; Alzoubi, Mohammad; Hilal, Mohammad Abu; Ruzzenente, Andrea; Ferrero, Alessandro; Herman, Paulo; Lee, Boram; Fuks, David; Cipriani, Federica; Liu, Qu; Aldrighetti, Luca; Liu, Rong; Han, Ho-Seong; Goh, Brian K P.
Afiliação
  • Kwak BJ; Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee JH; Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Chin KM; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore.
  • Syn NL; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Choi SH; Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Cheung TT; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, People's Republic of China.
  • Chiow AKH; Department of Surgery, Hepatopancreatobiliary Unit, Changi General Hospital, Singapore, Singapore.
  • Sucandy I; AdventHealth Tampa, Digestive Health Institute, Tampa, FL, USA.
  • Marino MV; General Surgery Department, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Prieto M; Oncologic Surgery Department, P. Giaccone University Hospital, Palermo, Italy.
  • Chong CC; Hepatobiliary Surgery and Liver Transplantation Unit, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Bilbao, Spain.
  • Choi GH; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, People's Republic of China.
  • Efanov M; Division of Hepatopancreatobiliary Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kingham TP; Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Scientific Center, Moscow, Russia.
  • Sutcliffe RP; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Troisi RI; Department of Hepatopancreatobiliary and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Pratschke J; Department of Clinical Medicine and Surgery, Division of HPB, Minimally Invasive and Robotic Surgery, Federico II University Hospital Naples, Naples, Federico, Italy.
  • Wang X; Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin, and Berlin Institute of Health, Berlin, Germany.
  • D'Hondt M; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Tang CN; Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.
  • Mishima K; Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, People's Republic of China.
  • Wakabayashi G; Center for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
  • Cherqui D; Center for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
  • Aghayan DL; Department of Hepatobiliary Surgery, Assistance Publique Hopitaux de Paris, Paul-Brousse Hospital, Centre Hepato-Biliaire, Villejuif, France.
  • Edwin B; The Intervention Centre and Department of Hepatic, Pancreatic and Biliary Surgery, Oslo University Hospital and Institute of Clinical Medicine, Oslo University, Oslo, Norway.
  • Scatton O; The Intervention Centre and Department of Hepatic, Pancreatic and Biliary Surgery, Oslo University Hospital and Institute of Clinical Medicine, Oslo University, Oslo, Norway.
  • Sugioka A; Department of Digestive, HBP and Liver Transplantation, Hopital Pitie-Salpetriere, APHP, Sorbonne Université, Paris, France.
  • Long TCD; Department of Surgery, Fujita Health University School of Medicine, Aichi, Japan.
  • Fondevila C; Department of Hepatopancreatobiliary Surgery, University Medical Center, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
  • Alzoubi M; General and Digestive Surgery, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
  • Hilal MA; General and Digestive Surgery, Hospital Universitario La Paz, IdiPAZ, CIBERehd, Madrid, Spain.
  • Ruzzenente A; Department of Surgery, University Hospital Southampton, Southampton, UK.
  • Ferrero A; Department of Surgery, University Hospital Southampton, Southampton, UK.
  • Herman P; Department of Surgery, Fondazione Poliambulanza, Brescia, Italy.
  • Lee B; General and Hepatobiliary Surgery, Department of Surgery, Dentistry, Gynecology and Pediatrics, University of Verona, GB Rossi Hospital, Verona, Italy.
  • Fuks D; Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.
  • Cipriani F; Liver Surgery Unit, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
  • Liu Q; Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Aldrighetti L; Department of Digestive, Oncologic and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.
  • Liu R; Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.
  • Han HS; Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, People's Republic of China.
  • Goh BKP; Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.
Surg Endosc ; 37(8): 5855-5864, 2023 08.
Article em En | MEDLINE | ID: mdl-37067594
ABSTRACT

INTRODUCTION:

Minimally invasive liver resection (MILR) is widely recognized as a safe and beneficial procedure in the treatment of both malignant and benign liver diseases. Hepatolithiasis has traditionally been reported to be endemic only in East Asia, but has seen a worldwide uptrend in recent decades with increasingly frequent and invasive endoscopic instrumentation of the biliary tract for a myriad of conditions. To date, there has been a woeful lack of high-quality evidence comparing the laparoscopic (LLR) and robotic (RLR) approaches to treatment hepatolithiasis.

METHODS:

This is an international multicenter retrospective analysis of 273 patients who underwent RLR or LRR for hepatolithiasis at 33 centers in 2003-2020. The baseline clinicopathological characteristics and perioperative outcomes of these patients were assessed. To minimize selection bias, 11 (48 and 48 cases of RLR and LLR, respectively) and 12 (37 and 74 cases of RLR and LLR, respectively) propensity score matching (PSM) was performed.

RESULTS:

In the unmatched cohort, 63 (23.1%) patients underwent RLR, and 210 (76.9%) patients underwent LLR. Patient clinicopathological characteristics were comparable between the groups after PSM. After 11 and 12 PSM, RLR was associated with less blood loss (p = 0.003 in 12 PSM; p = 0.005 in 11 PSM), less patients with blood loss greater than 300 ml (p = 0.024 in 12 PSM; p = 0.027 in 11 PSM), and lower conversion rate to open surgery (p = 0.003 in 12 PSM; p < 0.001 in 11 PSM). There was no significant difference between RLR and LLR in use of the Pringle maneuver, median Pringle maneuver duration, 30-day readmission rate, postoperative morbidity, major morbidity, reoperation, and mortality.

CONCLUSION:

Both RLR and LLR were safe and feasible for hepatolithiasis. RLR was associated with significantly less blood loss and lower open conversion rate.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Laparoscopia / Carcinoma Hepatocelular / Litíase / Procedimentos Cirúrgicos Robóticos / Hepatopatias / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Laparoscopia / Carcinoma Hepatocelular / Litíase / Procedimentos Cirúrgicos Robóticos / Hepatopatias / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article